Member LoginDividend CushionValue Trap |
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Oct 6, 2015
Attention to Pricing Issues Pressures Valeant
Along with the biotech industry as a whole, Valeant Pharmaceuticals has been the subject of negative publicity lately, and its shares have paid the price. Oct 5, 2015
Standard & Poor’s Notes Heightened Default Risks
The markets knew this was coming, but we think it’s worth repeating. How we’re playing the bounce in energy stocks… Oct 4, 2015
In The Name of Our Independence and Integrity…For Goodness Sake
The vicious attacks and slanderous falsehoods are inappropriate as they are damaging to our reputation. We won’t stand for it. Sep 29, 2015
Speculative Stocks Sinking
Risk appetite has been thrown out the window along with high-yield issuers. Sep 25, 2015
Janet Yellen, the Positive GDP Revision, and Nike’s Swoosh
Finally, there’s some good news, but nothing that could change the stormy overall picture. Sep 25, 2015
Caterpillar Prepares for Continued Pressure; Slashing Our Fair Value
Caterpillar recently announced a significant restructuring and cost reduction plan that will result in thousands of employees losing their jobs, but this isn’t the first time the firm has attempted to cut costs in recent years. Could the economic downturn affecting its most-served industries be more significant and prolonged than originally anticipated? Sep 25, 2015
Recent M&A Activity
Let’s take a look at some recent M&A activity across the market. Sep 24, 2015
China, Petrobras and the Circling Sharks
A key gauge of manufacturing activity in China plummets to Financial Crisis lows, Brazil’s Petrobras may be the first major casualty of the country’s deepening recession, and lenders are beginning to tighten the noose on overleveraged commodity producers in America. Sep 18, 2015
The Fed Freezes; Outlook as Bad as Feared or Worse?
The global economy may be far worse than even some pessimists believe, as the need for a continued ZIRP (zero interest-rate policy) remains the Fed’s tactic, at least for now.
prev12345678910111213141516171819202122232425
26272829303132333435363738394041424344454647484950 51525354555657585960616263646566676869707172737475 767778798081828384858687888990919293949596979899100 101102103104105106107108109110111112113114115116117118119120 121122123124125126127128129130131132133134135136137138139140 141142143144145146147148149150151152153154155156157158159160 161162163164165166167168169170171172173174175176177178179180 181182183184185186187188189190191192193194195196197198199200 201202next The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|
Performance at the aluminum giant speaks of more difficult times to come.